AI Article Synopsis

  • Polyreactivity refers to an antibody's ability to bind multiple distinct antigens, often seen in antibodies that respond to pathogens, but its specific role in anti-influenza virus responses is not well understood.
  • A study analyzing over 500 monoclonal antibodies from B cells induced by influenza vaccines and infections revealed that polyreactive antibodies target conserved hemagglutinin epitopes and are more commonly produced after exposure to new viral strains.
  • Additionally, polyreactivity enhances the binding strength of these antibodies by increasing their flexibility, and it's found that affinity-matured polyreactive B cells often originate from germline polyreactive B cells that are preferentially selected for effective immune responses over time.

Article Abstract

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772752PMC
http://dx.doi.org/10.1016/j.immuni.2020.10.005DOI Listing

Publication Analysis

Top Keywords

feature antibodies
8
influenza virus
8
targeting conserved
8
viral binding
8
conserved epitopes
8
polyreactive cells
8
polyreactive
5
polyreactive broadly
4
broadly neutralizing
4
cells
4

Similar Publications

In this study, the kidneys of ground squirrels (hibernated and nonhibernated), rabbits, and rats were examined macro and microanatomically. Kidney morphology was investigated by stereo microscopy, light microscopy, and scanning electron microscopy. Triple and immunohistochemical staining were performed for light microscopic examinations.

View Article and Find Full Text PDF

Background: -related schwannomatosis ( -SWN) is a debilitating condition that calls for robust treatment options. The defining feature of -SWN is the presence of bilateral vestibular schwannomas (VSs), which grow over time and can result in irreversible sensorineural hearing loss, significantly affecting the quality of life for those affected. At present, there are no FDA-approved medications specifically for treating VS or related hearing loss.

View Article and Find Full Text PDF

Background: Targeted therapies, including axitinib, a vascular endothelial growth factor receptor inhibitor, and sintilimab, a programmed cell death protein-1 inhibitor, have shown promise in the treatment of advanced renal cell carcinoma (RCC). Although their individual efficacies have been demonstrated, the potential synergistic effects of combining these two agents are still being explored.

Methods: This study retrospectively analysed patients with advanced RCC admitted to our hospital from January 2022 to December 2023.

View Article and Find Full Text PDF

Background: First-line treatment for advanced gastric adenocarcinoma (GAC) with human epidermal growth factor receptor 2 (HER2) is trastuzumab combined with chemotherapy. In clinical practice, HER2 positivity is identified through immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH), whereas deep learning (DL) can predict HER2 status based on tumor histopathological features. However, it remains uncertain whether these deep learning-derived features can predict the efficacy of anti-HER2 therapy.

View Article and Find Full Text PDF

Kawasaki disease (KD) is a leading cause of acquired heart disease in children, often resulting in coronary artery complications such as dilation, aneurysms, and stenosis. While intravenous immunoglobulin (IVIG) is effective in reducing immunologic inflammation, 10-15% of patients do not respond to initial therapy, and some show resistance even after two consecutive treatments. Predicting which patients will not respond to these two IVIG treatments is crucial for guiding treatment strategies and improving outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!